Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
Published online before print November 16, 2005, doi:10.1212/01.wnl.0000188760.53922.05)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000188760.53922.05v1
65/12/1954    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sato, T.
Right arrow Articles by Sakoda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sato, T.
Right arrow Articles by Sakoda, S.
NEUROLOGY 2005;65:1954-1957
© 2005 American Academy of Neurology
Brief Communications

Rapid disease progression correlates with instability of mutant SOD1 in familial ALS

T. Sato, MD*, T. Nakanishi, PhD*, Y. Yamamoto, MD, PhD, P. M. Andersen, MD, PhD, Y. Ogawa, MD, PhD, K. Fukada, MD, PhD, Z. Zhou, MD, PhD, F. Aoike, MD, F. Sugai, MD, S. Nagano, MD, PhD, S. Hirata, MD, M. Ogawa, MD, PhD, R. Nakano, MD, PhD, T. Ohi, MD, PhD, T. Kato, MD, PhD, M. Nakagawa, MD, T. Hamasaki, PhD, A. Shimizu, MD, PhD and S. Sakoda, MD, PhD

From the Department of Neurology (Drs. Sato, Yamamoto, Y. Ogawa, Fukada, Zhou, Aoike, Sugai, Nagano, and Sakoda), Department of Medical Statistics (Dr. Hamasaki), Osaka University Graduate School of Medicine, Suita, Osaka, Japan; Department of Clinical Pathology (Drs. Nakanishi and Shimizu), Osaka Medical College, Takatsuki, Osaka, Japan; Awaji Prefectural Hospital (Dr. Hirata), Sumoto, Hyogo, Japan; Aomori Prefectural Central Hospital (Dr. M. Ogawa), Aomori, Japan; Department of Neurology (Dr. Nakano), Brain Research Institute, Niigata University, Niigata, Japan; Division of Neurology (Dr. Ohi), Department of Internal Medicine, Miyazaki University School of Medicine, Miyazaki, Japan; Third Department of Internal Medicine (Dr. Kato), Yamagata University School of Medicine, Yamagata, Japan; Department of Neurology and Gerontology (Dr. Nakagawa), Research Institute for Neurological Diseases and Geriatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan; and Department of Neurology (Dr. Andersen), Umeå University Hospital, Umeå, Sweden.

Address correspondence and reprint requests to Dr. Yoichi Yamamoto, Department of Neurology D4, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan; e-mail: yamamoto{at}neurol.med.osaka-u.ac.jp

Studies on the clinical course of familial ALS suggest that the duration of illness is relatively consistent for each mutation but variable among the different mutations. The authors analyzed the relative amount of mutant compared with normal SOD1 protein in the erythrocytes from 29 patients with ALS with 22 different mutations. Turnover of mutant SOD1 correlated with a shorter disease survival time.

This article was previously published in electronic format as an Expedited E-Pub on November 16, 2005, at www.neurology.org.

* These authors contributed equally to this work.

Supported by Grants-in-Aid for Scientific Research in Japan and by a grant on Specific Diseases (Y.I.) from the Ministry of Health and Welfare, Japan.

Disclosure: The authors report no conflicts of interest.

Received August 4, 2004. Accepted in final form September 1, 2005.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
C. S. Lobsiger, S. Boillee, M. McAlonis-Downes, A. M. Khan, M. L. Feltri, K. Yamanaka, and D. W. Cleveland
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice
PNAS, March 17, 2009; 106(11): 4465 - 4470.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. Vande Velde, T. M. Miller, N. R. Cashman, and D. W. Cleveland
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria
PNAS, March 11, 2008; 105(10): 4022 - 4027.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. Jaarsma, E. Teuling, E. D. Haasdijk, C. I. De Zeeuw, and C. C. Hoogenraad
Neuron-Specific Expression of Mutant Superoxide Dismutase Is Sufficient to Induce Amyotrophic Lateral Sclerosis in Transgenic Mice
J. Neurosci., February 27, 2008; 28(9): 2075 - 2088.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Gruzman, W. L. Wood, E. Alpert, M. D. Prasad, R. G. Miller, J. D. Rothstein, R. Bowser, R. Hamilton, T. D. Wood, D. W. Cleveland, et al.
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
PNAS, July 24, 2007; 104(30): 12524 - 12529.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Yamanaka and D. W. Cleveland
Determinants of rapid disease progression in ALS
Neurology, December 27, 2005; 65(12): 1859 - 1860.
[Full Text] [PDF]